A recent study demonstrated that the fusion protein CBFB::MYH11 impairs the normal interaction between DNMT3A and RUNX1, leading to the hypomethylation and the hyperexpression of genes involved in AML progression [51]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.